Compare Amylx Pharmaceuticals Inc (AMLX) vs Aspen Aerogels Inc (ASPN) Price & Performance

Amylx Pharmaceuticals IncTrade

Aspen Aerogels IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Aspen Aerogels Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Aspen Aerogels Inc trades at $6.15 (market cap $509.55M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 5.2× Aspen Aerogels Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Aspen Aerogels Inc nearer its low. Which is the better fit depends on your goals.

	AMLX	ASPN
Market Cap	$2.64B	$509.55M
Sector	Health	Technology
52-Week High	$24.19	$8.82
52-Week Low	$7.82	$2.57
Enterprise Value	$2.39B	$482.96M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMLX

Amylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026Seeking Alpha · 4 days agoBullish View details →

ASPN

Aspen Aerogels posts stronger Q2 revenue and EBITDA, signals further recovery in Q3 despite challenges.Seeking Alpha · 1 day agoNeutral Aspen Aerogels poised for growth with EV battery barriers and new material uses in data centers and grids.Seeking Alpha · 2 days agoBullish View details →

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

About Aspen Aerogels Inc

Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.